Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

1.

The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: protocol for a systematic review and network meta-analysis of randomized controlled trials.

Catalá-López F, Hutton B, Núñez-Beltrán A, Mayhew AD, Page MJ, Ridao M, Tobías A, Catalá MA, Tabarés-Seisdedos R, Moher D.

Syst Rev. 2015 Feb 27;4:19. doi: 10.1186/s13643-015-0005-7.

2.

When are statins cost-effective in cardiovascular prevention? A systematic review of sponsorship bias and conclusions in economic evaluations of statins.

Catalá-López F, Sanfélix-Gimeno G, Ridao M, Peiró S.

PLoS One. 2013 Jul 8;8(7):e69462. doi: 10.1371/journal.pone.0069462. Print 2013. Review.

3.

Trends of uncontrolled blood pressure in Spain: an updated meta-regression analysis.

Catalá-López F, Ridao M, Sanfélix-Gimeno G, Peiró S.

J Hypertens. 2013 Mar;31(3):630-1. doi: 10.1097/HJH.0b013e32835c6d19. No abstract available.

PMID:
23615217
4.

Cost-effectiveness of pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: qualitative synthesis of scientific evidence.

Catalá-López F, Ridao M, Sanfélix-Gimeno G, Peiró S.

Rev Psiquiatr Salud Ment. 2013 Oct-Dec;6(4):168-77. doi: 10.1016/j.rpsm.2012.12.002. Epub 2013 Feb 27. Review. English, Spanish.

5.

Prevalence of attention deficit hyperactivity disorder among children and adolescents in Spain: a systematic review and meta-analysis of epidemiological studies.

Catalá-López F, Peiró S, Ridao M, Sanfélix-Gimeno G, Gènova-Maleras R, Catalá MA.

BMC Psychiatry. 2012 Oct 12;12:168. doi: 10.1186/1471-244X-12-168. Review.

6.

Coauthorship and institutional collaborations on cost-effectiveness analyses: a systematic network analysis.

Catalá-López F, Alonso-Arroyo A, Aleixandre-Benavent R, Ridao M, Bolaños M, García-Altés A, Sanfélix-Gimeno G, Peiró S.

PLoS One. 2012;7(5):e38012. doi: 10.1371/journal.pone.0038012. Epub 2012 May 29.

7.

Burden of disease assessment with summary measures of population health for the Region of Valencia, Spain: a population-based study.

Catalá-López F, Gènova-Maleras R, Ridao M, Álvarez E, Sanfélix-Gimeno G, Morant C, Peiró S.

Med Clin (Barc). 2013 Apr 20;140(8):343-50. doi: 10.1016/j.medcli.2012.01.028. Epub 2012 Apr 11.

PMID:
22498350
8.

Timing of surgery for hip fracture and in-hospital mortality: a retrospective population-based cohort study in the Spanish National Health System.

Librero J, Peiró S, Leutscher E, Merlo J, Bernal-Delgado E, Ridao M, Martínez-Lizaga N, Sanfélix-Gimeno G.

BMC Health Serv Res. 2012 Jan 18;12:15. doi: 10.1186/1472-6963-12-15.

9.

Control of arterial hypertension in Spain: a systematic review and meta-analysis of 76 epidemiological studies on 341 632 participants.

Catalá-López F, Sanfélix-Gimeno G, García-Torres C, Ridao M, Peiró S.

J Hypertens. 2012 Jan;30(1):168-76. doi: 10.1097/HJH.0b013e32834d30ec. Review.

PMID:
22025240
10.

Safety of specific immunotherapy using a depigmented and polymerised extract of Dermatophagoides pteronyssinus in children under five years of age.

Hernández N, Ibero M, Ridao M, Artigas R, Viñas M, Castillo MJ.

Allergol Immunopathol (Madr). 2011 Sep-Oct;39(5):267-70. doi: 10.1016/j.aller.2010.09.002. Epub 2011 Feb 18.

PMID:
21334128
11.

[Variability in Spanish National Health System hospital emergency services utilization].

Peiró S, Librero J, Ridao M, Bernal-Delgado E; Grupo de Variaciones en la Práctica Médica en el Sistema Nacional de Salud.

Gac Sanit. 2010 Jan-Feb;24(1):6-12. doi: 10.1016/j.gaceta.2009.06.008. Epub 2009 Oct 31. Spanish.

12.

Economic evaluation of varicella vaccination in Spain: results from a dynamic model.

Lenne X, Diez Domingo J, Gil A, Ridao M, Lluch JA, Dervaux B.

Vaccine. 2006 Nov 17;24(47-48):6980-9. Epub 2006 May 4.

PMID:
16860909
13.

A Risk-based Model Predictive Control Approach to Adaptive Interventions in Behavioral Health.

Zafra-Cabeza A, Rivera DE, Collins LM, Ridao MA, Camacho EF.

IEEE Trans Control Syst Technol. 2011 Jul 1;19(4):891-901.

14.

[Research and advertisement. Differences in the effectiveness of alendronate according to risk groups].

Peiró S, Ortún Rubio V, Meneu R, García-Altés A, Ridao M, Bernal Delgado E.

Aten Primaria. 2001 Apr 30;27(7):528-30. Spanish. No abstract available.

PMID:
11334607
15.

A cost benefit analysis of routine varicella vaccination in Spain.

Díez Domingo J, Ridao M, Latour J, Ballester A, Morant A.

Vaccine. 1999 Mar 17;17(11-12):1306-11.

PMID:
10195765
16.

Variations in diagnostic and therapeutic intensity between home and conventional hospitalization.

Oterino-de-la-Fuente D, Peiró S, Ridao M, Marchan C.

Int J Qual Health Care. 1998 Aug;10(4):331-8.

17.

[The health costs of alcoholism].

Portella E, Ridao M, Salvat M, Carrillo E.

Aten Primaria. 1998 Sep 30;22(5):279-84. Spanish.

PMID:
9835133
18.

Cisapride treatment changes the evolution of infant asthma with gastroesophageal reflux.

Ibero M, Ridao M, Artigas R, Martín B, Tresserras R.

J Investig Allergol Clin Immunol. 1998 May-Jun;8(3):176-9.

PMID:
9684192
19.

[Hospital at home and conventional hospitalization. An economic evaluation].

Oterino de la Fuente D, Ridao M, Peiró S, Marchan C.

Med Clin (Barc). 1997 Jul 5;109(6):207-11. Spanish.

PMID:
9289549
20.

[Pathologic puberty and dysgerminoma of the ovary].

Marcos MV, Ridao ML, Martínez Vila I, Marco V.

An Esp Pediatr. 1987 Apr;26(4):308-10. Spanish. No abstract available.

PMID:
3605886
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk